Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

HILIC/ESI-MS determination of gangliosides and other polar lipid classes in renal cell carcinoma and surrounding normal tissues.

Hájek R, Lísa M, Khalikova M, Jirásko R, Cífková E, Študent V Jr, Vrána D, Opálka L, Vávrová K, Matzenauer M, Melichar B, Holčapek M.

Anal Bioanal Chem. 2018 Oct;410(25):6585-6594. doi: 10.1007/s00216-018-1263-8. Epub 2018 Jul 28.

PMID:
30054694
2.

MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.

Lettlova S, Brynychova V, Blecha J, Vrana D, Vondrusova M, Soucek P, Truksa J.

Cell Physiol Biochem. 2018;46(6):2601-2615. doi: 10.1159/000489687. Epub 2018 May 7.

3.

Immunotherapy in mucosal melanoma: a case report and review of the literature.

Studentova H, Kalabova H, Koranda P, Chytilova K, Kucerova L, Melichar B, Vrana D.

Oncotarget. 2018 Apr 3;9(25):17971-17977. doi: 10.18632/oncotarget.24727. eCollection 2018 Apr 3.

4.

ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer.

Vrana D, Hlavac V, Brynychova V, Vaclavikova R, Neoral C, Vrba J, Aujesky R, Matzenauer M, Melichar B, Soucek P.

Int J Mol Sci. 2018 Mar 15;19(3). pii: E868. doi: 10.3390/ijms19030868. Review.

5.

[Current Status of Checkpoint Inhibitors in the Treatment of Esophageal and Gastric Tumors - Overview of Studies].

Vrána D, Matzenauer M, Melichar B.

Klin Onkol. 2017 Winter;31(1):35-39. doi: 10.14735/amko201835. Czech.

PMID:
29488776
6.

Selective changes in cholesterol metabolite levels in plasma of breast cancer patients after tumor removal.

Soucek P, Vrana D, Ueng YF, Wei S, Kozevnikovova R, Guengerich FP.

Clin Chem Lab Med. 2018 Feb 23;56(3):e78-e81. doi: 10.1515/cclm-2017-0409. No abstract available.

7.

Stereotactic radiotherapy in the treatment of local recurrences of esophageal cancer.

Matzenauer M, Vrána D, Vlachová Z, Aujesky R, Vrba R, Neoral C, Melichar B.

Oncol Lett. 2017 Mar;13(3):1807-1810. doi: 10.3892/ol.2017.5605. Epub 2017 Jan 17.

8.

MALDI Orbitrap Mass Spectrometry Profiling of Dysregulated Sulfoglycosphingolipids in Renal Cell Carcinoma Tissues.

Jirásko R, Holčapek M, Khalikova M, Vrána D, Študent V, Prouzová Z, Melichar B.

J Am Soc Mass Spectrom. 2017 Aug;28(8):1562-1574. doi: 10.1007/s13361-017-1644-9. Epub 2017 Mar 30.

PMID:
28361385
9.

Expression of oxysterol pathway genes in oestrogen-positive breast carcinomas.

Kloudova A, Brynychova V, Vaclavikova R, Vrana D, Gatek J, Mrhalova M, Kodet R, Soucek P.

Clin Endocrinol (Oxf). 2017 Jun;86(6):852-861. doi: 10.1111/cen.13337. Epub 2017 Apr 24.

PMID:
28342201
10.

Potential Predictive Role of MicroRNAs in the Neoadjuvant Treatment of Esophageal Cancer.

Vrana D, Matzenauer M, Aujesky R, Vrba R, Neoral C, Melichar B, Souček P.

Anticancer Res. 2017 Feb;37(2):403-412. Review.

PMID:
28179285
11.

Prognostic Influence of Internal Mammary Node Drainage in Patients with Early-stage Breast Cancer.

Lukesova L, Vrana D, Svach I, Zlamalova N, Gatek J, Vlachová Z, Matzenauer M, Koranda P, Hruzova K, Tichy T, Melichar B.

Anticancer Res. 2016 Dec;36(12):6641-6646.

PMID:
27919996
12.

Treatment of brain metastases.

Matzenauer M, Vrana D, Melichar B.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Dec;160(4):484-490. doi: 10.5507/bp.2016.058. Epub 2016 Nov 23. Review.

13.

Correlation of lipidomic composition of cell lines and tissues of breast cancer patients using hydrophilic interaction liquid chromatography/electrospray ionization mass spectrometry and multivariate data analysis.

Cífková E, Lísa M, Hrstka R, Vrána D, Gatěk J, Melichar B, Holčapek M.

Rapid Commun Mass Spectrom. 2017 Feb 15;31(3):253-263. doi: 10.1002/rcm.7791.

PMID:
27862481
14.

Genetic and functional analyses do not explain the association of high PRC1 expression with poor survival of breast carcinoma patients.

Brynychova V, Ehrlichova M, Hlavac V, Nemcova-Furstova V, Pecha V, Leva J, Trnkova M, Mrhalova M, Kodet R, Vrana D, Kovar J, Vaclavikova R, Gut I, Soucek P.

Biomed Pharmacother. 2016 Oct;83:857-864. doi: 10.1016/j.biopha.2016.07.047. Epub 2016 Aug 6.

PMID:
27505863
15.

Radiotherapy management of brain metastases using conventional linear accelerator.

Matzenauer M, Vrana D, Vlachova Z, Cwiertka K, Kalita O, Melichar B.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Sep;160(3):412-6. doi: 10.5507/bp.2016.043. Epub 2016 Sep 13.

16.

Transcript expression and genetic variability analysis of caspases in breast carcinomas suggests CASP9 as the most interesting target.

Brynychova V, Hlavac V, Ehrlichova M, Vaclavikova R, Nemcova-Furstova V, Pecha V, Trnkova M, Mrhalova M, Kodet R, Vrana D, Gatek J, Bendova M, Vernerova Z, Kovar J, Soucek P.

Clin Chem Lab Med. 2017 Jan 1;55(1):111-122. doi: 10.1515/cclm-2016-0271.

PMID:
27327132
17.

Treatment of brain metastases of renal cell cancer with combined hypofractionated stereotactic radiotherapy and whole brain radiotherapy with hippocampal sparing.

Vrána D, Študentová H, Matzenauer M, Vlachová Z, Cwiertka K, Gremlica D, Kalita O.

Oncol Lett. 2016 Jun;11(6):3777-3781. Epub 2016 Apr 15.

18.

Prognostic Significance of Serum and Urinary Neopterin Concentrations in Patients with Rectal Carcinoma Treated with Chemoradiation.

Zezulová M, Bartoušková M, Hlídková E, Juráňová J, Červinková B, Kasalová E, Adam T, Krčmová LK, Solichová D, Cwiertka K, Vrána D, Melichar B.

Anticancer Res. 2016 Jan;36(1):287-92.

PMID:
26722055
19.

Management of internal mammary nodes in early-stage breast cancer: response to comments by De Cicco et al.

Vrana D, Lukesova L, Gatek J, Melichar B, Vlachova Z.

Tumori. 2016 Feb 4;102(1):e7. doi: 10.5301/tj.5000420. No abstract available.

PMID:
26429646
20.

Lipidomic differentiation between human kidney tumors and surrounding normal tissues using HILIC-HPLC/ESI-MS and multivariate data analysis.

Cífková E, Holčapek M, Lísa M, Vrána D, Melichar B, Študent V.

J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Sep 1;1000:14-21. doi: 10.1016/j.jchromb.2015.07.011. Epub 2015 Jul 13.

PMID:
26207874

Supplemental Content

Loading ...
Support Center